Stay updated on Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial page.

Latest updates to the Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedOnly a minor site revision update was made (Revision: v3.3.2 added and Revision: v3.2.0 removed), with no changes to the study record history or its contents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe funding-lapse warning on the page was removed. The page no longer displays the prior disclaimer that updates may be delayed due to appropriations.SummaryDifference0.4%

- Check42 days agoChange DetectedA new version was posted in the study record history, updating the Study Status and Recruitment Status sections. Related details such as Contacts/Locations and Outcome Measures may also have been updated.SummaryDifference0.1%

- Check71 days agoChange Detected- Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.SummaryDifference9%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version is available.SummaryDifference0.2%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.5%

Stay in the know with updates to Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Untreated BRAFv600+ Melanoma Clinical Trial page.